Alkermes, Inc. recalls VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured an
Recalled September 3, 2014 · FDA recall D-1556-2014 · Alkermes
Hazard
Customer complaints for failure to deliver the dose. · FDA Class II
Units
4,364 vials
Sold at
Nationwide
Description
Customer complaints for failure to deliver the dose.
Product
VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451.
Manufacturer(s)
Alkermes, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →